Zim Laboratories Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting

ZIM Labs' board met to approve its Q1 FY26 consolidated financial results. The company reported a net loss of ₹1.87 Cr, with revenue from operations at ₹71.76 Cr for the quarter ending June 30, 2025. This marks a notable decline from previous periods.

Strategically, the board greenlit an investment of up to AED 4.5 lakh by its subsidiary into ZIM Scientific Office L.L.C. to expand business in the GCC region. Conversely, it approved the closure of another step-down subsidiary, ZIM Laboratories Middle East DMCC. The board also appointed Protiviti India Member Private Limited as Internal Auditors for FY2025-26.